Femasys has gained approval for its FemaSeed Intratubal Insemination product and two diagnostic devices from the Ministry of ...

Blocked fallopian tubes, also known as tubal occlusion, are a significant cause of infertility in women, both globally and in India. Fallopian tubes are essential for fertility as they allow the ...

Regulatory approval follows FemaSeed U.S. FDA-clearance announced September 2023 and EU CE mark approval announced June ...

Infertility in Nigeria is a significant public health issue, affecting many couples across the country. It is estimated that around ...

Femasys (FEMY) in women’s health worldwide, with a broad portfolio of disruptive, accessible in-office therapeutic and diagnostic products, ...

or tubal obstruction. Of the approximately 5 million infertile women in the United States, it is estimated that 2 million (40%) have medical or hormonal infertility; 1 million (20%) have ...

OE, prior cystectomy (group 2) 112 Not reported but all <6 cm 19.60 7.9 ± 4.2 Tubal factor infertility (group 3) 174 6.6 ± 3.5, NS EST: Ethanol scleropathy; FSH: Follicle.stimulating hormone ...

Interest in tubal ligations and vasectomies has skyrocketed in the past two years, according to research and health-care providers.

Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive ...